HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular mechanisms underlying selective cytotoxic activity of BZL101, an extract of Scutellaria barbata, towards breast cancer cells.

Abstract
We studied the mechanism of the cytotoxic activity of BZL101, an aqueous extract from the herb Scutellaria barbata D. Don, which is currently in phase II clinical trial in patients with advanced breast cancer. The phase I trial showed favorable toxicity profile and promising efficacy. We report here that BZL101 induces cell death in breast cancer cells but not in non-transformed mammary epithelial cells. This selective cytotoxicity is based on strong induction by BZL101 of reactive oxygen species (ROS) in tumor cells. As a consequence, BZL101 treated cancer cells develop extensive oxidative DNA damage and succumb to necrotic death. Data from the expression profiling of cells treated with BZL101 are strongly supportive of a death pathway that involves oxidative stress, DNA damage and activation of death-promoting genes. In breast cancer cells oxidative damage induced by BZL101 leads to the hyperactivation of poly (ADP-ribose) polymerase (PARP), followed by a sustained decrease in levels of NAD and depletion of ATP, neither of which are observed in non-transformed cells. The hyperactivation of PARP is instrumental in the necrotic death program induced by BZL101, because inhibition of PARP results in suppression of necrosis and activation of the apoptotic death program. BZL101 treatment leads to the inhibition of glycolysis selectively in tumor cells, evident from the decrease in the enzymatic activities within the glycolytic pathway and the inhibition of lactate production. Because tumor cells frequently rely on glycolysis for energy production, the observed inhibition of glycolysis is likely a key factor in the energetic collapse and necrotic death that occurs selectively in breast cancer cells. The promising selectivity of BZL101 towards cancer cells is based on metabolic differences between highly glycolytic tumor cells and normal cells.
AuthorsSylvia Fong, Mark Shoemaker, Jaclyn Cadaoas, Alvin Lo, Wayne Liao, Mary Tagliaferri, Isaac Cohen, Emma Shtivelman
JournalCancer biology & therapy (Cancer Biol Ther) Vol. 7 Issue 4 Pg. 577-86 (Apr 2008) ISSN: 1555-8576 [Electronic] United States
PMID18305410 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Plant Extracts
  • Reactive Oxygen Species
  • Scutellaria barbata extract
  • NAD
  • Adenosine Triphosphate
  • Poly(ADP-ribose) Polymerases
Topics
  • Adenosine Triphosphate (metabolism)
  • Antineoplastic Agents (pharmacology)
  • Apoptosis
  • Breast Neoplasms (metabolism)
  • Cell Line, Tumor
  • DNA Damage
  • Glycolysis (drug effects)
  • Humans
  • NAD (metabolism)
  • Oxidative Stress
  • Plant Extracts (pharmacology)
  • Poly(ADP-ribose) Polymerases (metabolism)
  • Reactive Oxygen Species (metabolism)
  • Scutellaria

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: